These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19824894)
1. Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods. Ajmani S; Karanam S; Kulkarni SA Chem Biol Drug Des; 2009 Dec; 74(6):582-95. PubMed ID: 19824894 [TBL] [Abstract][Full Text] [Related]
2. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
3. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors. Park H; Bhattarai BR; Ham SW; Cho H Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068 [TBL] [Abstract][Full Text] [Related]
4. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations. Fang L; Zhang H; Cui W; Ji M J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546 [TBL] [Abstract][Full Text] [Related]
5. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase. Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one. Wang JF; Gong K; Wei DQ; Li YX; Chou KC Protein Eng Des Sel; 2009 Jun; 22(6):349-55. PubMed ID: 19380334 [TBL] [Abstract][Full Text] [Related]
7. Interpretation of the binding affinities of PTP1B inhibitors with the MM-GB/SA method and the X-score scoring function. Zhang X; Li X; Wang R J Chem Inf Model; 2009 Apr; 49(4):1033-48. PubMed ID: 19320460 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors. Gupta S; Pandey G; Rahuja N; Srivastava AK; Saxena AK Bioorg Med Chem Lett; 2010 Oct; 20(19):5732-4. PubMed ID: 20797859 [TBL] [Abstract][Full Text] [Related]
9. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects. Bhattarai BR; Kafle B; Hwang JS; Khadka D; Lee SM; Kang JS; Ham SW; Han IO; Park H; Cho H Bioorg Med Chem Lett; 2009 Nov; 19(21):6161-5. PubMed ID: 19783142 [TBL] [Abstract][Full Text] [Related]
10. Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors. Patankar SJ; Jurs PC J Chem Inf Comput Sci; 2003; 43(3):885-99. PubMed ID: 12767147 [TBL] [Abstract][Full Text] [Related]
11. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures. Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162 [TBL] [Abstract][Full Text] [Related]
12. Structure-based design of protein tyrosine phosphatase-1B inhibitors. Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor. Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216 [TBL] [Abstract][Full Text] [Related]
14. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. Floriano WB; Vaidehi N; Zamanakos G; Goddard WA J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820 [TBL] [Abstract][Full Text] [Related]
15. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Douty B; Wayland B; Ala PJ; Bower MJ; Pruitt J; Bostrom L; Wei M; Klabe R; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP; Yue EW Bioorg Med Chem Lett; 2008 Jan; 18(1):66-71. PubMed ID: 18037290 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies. Saxena AK; Pandey G; Gupta S; Singh AB; Srivastava AK Bioorg Med Chem Lett; 2009 Apr; 19(8):2320-3. PubMed ID: 19282172 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity. Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B. Lin L; Shen Q; Chen GR; Xie J Bioorg Med Chem; 2008 Nov; 16(22):9757-63. PubMed ID: 18922697 [TBL] [Abstract][Full Text] [Related]